Weak immunogenicity of SARS-CoV-2 vaccine in patients with hematologic malignancies혈액 학적 악성 종양 환자에서 SARS-COV-2 백신의 약한 면역 원성Article Published on 2021-08-102022-09-01 Journal: Blood Cancer Journal [Category] [DOI] 10.1038/s41408-021-00534-z PMC 바로가기 [Article Type] Article
The neutralizing antibody response post COVID-19 vaccination in patients with myeloma is highly dependent on the type of anti-myeloma treatment골수종 환자의 Covid-19 백신 접종 후 중화 항체 반응은 항-미 일종 치료의 유형에 크게 의존합니다.Multicenter Study Published on 2021-08-022022-09-01 Journal: Blood Cancer Journal [Category] [DOI] 10.1038/s41408-021-00530-3 PMC 바로가기 [Article Type] Multicenter Study
Complete response in a frail patient with high-grade B-cell lymphoma to only one cycle of R-CHOP or to prolonged COVID-19?고등급 B 세포 림프종을 가진 허약한 환자에서 R-CHOP의 한 주기 또는 연장된 COVID-19에 대한 완전한 반응?Meta-Analysis Published on 2021-08-012022-09-11 Journal: Seminars in oncology [Category] [DOI] 10.1053/j.seminoncol.2021.11.001 PMC 바로가기 [Article Type] Meta-Analysis
Decline and incomplete recovery in cancer diagnoses during the COVID-19 pandemic in Belgium: a year-long, population-level analysis벨기에의 COVID-19 전염병 동안 암 진단의 감소 및 불완전 회복: 1년 동안의 인구 수준 분석Article Published on 2021-08-012022-09-11 Journal: ESMO open [Category] [DOI] 10.1016/j.esmoop.2021.100197 PMC 바로가기 [Article Type] Article
Post-Vaccination Anti-SARS-CoV-2-Antibody Response in Patients with Multiple Myeloma Correlates with Low CD19+ B-Lymphocyte Count and Anti-CD38 TreatmentArticle Published on 2021-07-282022-10-31 Journal: Cancers [Category] [DOI] 10.3390/cancers13153800 PMC 바로가기 [Article Type] Article
Successful Chimeric Antigen Receptor (CAR) T-Cell Treatment in Aggressive Lymphoma Despite Coronavirus Disease 2019 (CoVID-19) and Prolonged Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Replication – Case ReportOncology Published on 2021-07-142022-10-31 Journal: Frontiers in Oncology [Category] [DOI] 10.3389/fonc.2021.706431 PMC 바로가기 [Article Type] Oncology
Preinfection laboratory parameters may predict COVID‐19 severity in tumor patients사전 감염 실험실 파라미터는 종양 환자의 Covid -19 중증도를 예측할 수 있습니다.Multicenter Study Published on 2021-06-132022-08-31 Journal: Cancer Medicine [Category] [DOI] 10.1002/cam4.4023 PMC 바로가기 [Article Type] Multicenter Study
Low titers of SARS-CoV-2 neutralizing antibodies after first vaccination dose in cancer patients receiving checkpoint inhibitors체크포인트 억제제를 투여받는 암 환자에서 첫 접종 후 낮은 역가의 SARS-CoV-2 중화항체Letter to the Editor Published on 2021-05-312022-09-12 Journal: Journal of Hematology & Oncology [Category] [DOI] 10.1186/s13045-021-01099-x PMC 바로가기 [Article Type] Letter to the Editor
Clinical Characteristics of COVID-19-Infected Cancer Patients in Pakistan: Differences Between Survivors and Non-SurvivorsOncology Published on 2021-05-202022-10-31 Journal: Frontiers in Oncology [Category] [DOI] 10.3389/fonc.2021.655634 PMC 바로가기 [Article Type] Oncology
Factors associated with SARS-CoV-2 infection and outcome in patients with solid tumors or hematological malignancies: a single-center studyOriginal Article Published on 2021-04-142022-10-28 Journal: Supportive Care in Cancer [Category] [DOI] 10.1007/s00520-021-06175-z PMC 바로가기 [Article Type] Original Article